Creating a bank of tumor tissue samples for research

Is this trial a fit for you?

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This project aims to establish a comprehensive tumor bank that collects tissue samples from patients with various types of tumors, including benign and malignant cases, as well as healthy controls. The samples will be systematically gathered alongside corresponding clinical data to support future research in cancer diagnosis and therapy. The tumor bank will facilitate translational oncology by providing essential biological materials for analyzing tumor markers and genetic characteristics, ultimately aiming to improve clinical outcomes for cancer patients.

Why it matters

Who can join: the full rules

Inclusion Criteria:

* Male/Female
* Age 18 to 90 years max.
* Just one current known malignant disease or just one current inflammatory disease

Exclusion Criteria:

* Inflammatory disease and malignant disease
* multiple malignancies
* multiple diseases
* underage

Where it's running

• Medical University Vienna, Dptm. of Obstetrics & Gynaecology
  Vienna, Austria Recruiting
• University Hospitals Leuven - Department of Obstetrics and Gynaecology
  Leuven, Belgium Completed
• Charité University - Campus Virchow Chlinic
  Berlin, Germany Active not recruiting

Study contacts

• Principal investigator: Robert Zeillinger, Prof.Dr. — Medical University of Vienna, Dptm. of Obstetrics & Gynaecology
• Study coordinator: Robert Zeillinger, Prof.Dr.
• Email: robert.zeillinger@meduniwien.ac.at
• Phone: +43140400

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

• Creating a tumor bank for blood samples from cancer patients and healthy controls

  This study is collecting blood samples from cancer patients and healthy people to help researchers find better ways to diagnose and treat cancer.

  Recruiting Medical University of Vienna · Innsbruck and 5 other locations · NCT01763125

• Methylscape test in body fluids for multi-cancer detection in Colombia

  A simple blood, urine, or saliva test called Methylscape is being tested to see if it can detect multiple cancers and identify where the signal is coming from, using people with cancer and healthy volunteers in Colombia.

  Recruiting Centro de Tratamiento e Investigación sobre Cáncer, Luis Carlos Sarmiento Angulo · Bogotá, Bogota D.C. · NCT07741435

• LY4337713 for people with FAP-positive ovarian, breast, pancreatic, colorectal, or esophageal cancers

  This trial tests LY4337713, a FAP-targeted lutetium-177 therapy, in people with advanced cancers that show high levels of fibroblast activation protein (FAP).

  Recruiting at 17 sites Phase 1 Eli Lilly and Company · Newport Beach, California and 29 other locations · NCT07213791

• High-sensitivity blood test to detect and monitor multiple cancers

  This study will test a high-sensitivity blood test that looks for tumor DNA to detect and follow several common cancers in adults with those cancers or people having routine health screenings.

  Recruiting Yonsei University · Seoul · NCT07035587

• Benchmarking AI language models against tumor boards for oncology treatment decisions

  This project tests whether frontier AI language models can match the treatment recommendations of multidisciplinary tumor boards for common cancers using standardized synthetic cases.

  Recruiting Assistance Publique - Hôpitaux de Paris · Boulogne-Billancourt and 4 other locations · NCT07739121

• Dabrafenib and trametinib for rare cancers with BRAF V600 mutations

  This arm tests whether dabrafenib and trametinib can help adults, children, and teens with cancers that have a BRAF V600 mutation.

  Recruiting at 15 sites Phase 2/3 Cancer Research UK · Belfast and 26 other locations · NCT07440290

How to take part

1. Review the eligibility criteria above with your treating physician.
2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.